Chloroplast and Mitochondria Cytosine Base Editors in Plants

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genome editing technologies, such as CRISPR, face challenges in efficiently editing chloroplast and mitochondrial genomes in plants due to difficulties in delivering guide RNA into organelles, and existing methods like mtTALENs have low gene editing efficiency.

Innovation Solution

Development of cytosine base editors using plant-specific targeting peptides and a TALE array protein with a deaminase and uracil glycosylase inhibitor, encoded in DNA vectors, to specifically target and edit chloroplast and mitochondrial genomes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If CRISPR-based genome editing is used, then nuclear genome editing is efficient, but organelle genome editing is not feasible due to difficulty in delivering guide RNA into organelles

Engineering Contradiction:
Improvegene editing efficiencyVSAvoiddelivery of guide RNA into organelles
Core Design Contradiction:
ProductivityVSEase of operation

Solution Approach 1:

The invention extracts and removes the guide RNA component from the CRISPR system, replacing it with a TALE-based DNA binding domain that directly targets the organelle genome without requiring RNA delivery. This eliminates the delivery barrier while maintaining targeted editing capability.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The TALE array protein serves as an intermediary between the targeting peptide and the deaminase enzyme, enabling specific DNA binding and positioning the deaminase at the correct location for base editing without requiring guide RNA.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If mtTALENs are used to target mitochondria, then mitochondrial targeting is achieved, but gene editing efficiency is very low due to inefficient repair of DSBs

Engineering Contradiction:
Improvemitochondrial targetingVSAvoidgene editing efficiency
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The invention extracts and removes the endonuclease domain from the TALEN system, eliminating double-stranded DNA breaks entirely. Instead, it uses a deaminase enzyme to perform direct base conversion, bypassing the inefficient DSB repair pathway in mitochondria.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention replaces the mechanical DSB creation and repair mechanism with a chemical deamination reaction catalyzed by the deaminase enzyme, which directly converts cytosine to uracil without requiring DNA breakage or complex repair pathways.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Measurement precision

If DddA-derived cytosine base editors are used in human cells, then C·G to T·A conversions are achieved with high target specificity, but the system is not adapted for plant organelles

Engineering Contradiction:
Improvetarget specificityVSAvoidadaptability to plant organelles
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The invention modifies the DddA base editor by adding plant-specific chloroplast or mitochondrial targeting peptides to the N-terminus, enabling the enzyme to localize to plant organelles while maintaining its cytosine deaminase activity and target specificity.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention creates a chimeric protein combining the plant-specific targeting peptide, the TALE array protein for DNA recognition, and the DddA deaminase domain for base editing, resulting in a composite enzyme adapted for plant organelle editing with both specificity and organelle targeting capability.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The solution achieves high target specificity and efficiency in C·G to T·A conversions in plant chloroplast and mitochondrial DNA, overcoming previous limitations in organelle editing.

Implementation Method 1

DddA-derived cytosine base editors (DdCBEs) that catalyze C·G to T·A conversions

Methodology Applied
Scientific EffectCytosine deamination: Chemical Bonding

Implementation Method 2

TALEs of bacterial origin recognize DNA sequences of target sites following a TALE DNA recognition code

Methodology Applied
Scientific EffectDNA recognition and binding: Chemical Bonding

Implementation Method 3

fused with a mitochondrial transition peptide and an uracil glycosylase inhibitor (UGI)

Methodology Applied
Scientific EffectEnzyme inhibition: Enzyme

Data Source

PatentUS20240229051A9Chloroplast cytosine base editors and mitochondria cytosine base editors in plants
Publication Date: 2024.07.11 THE CURATORS OF THE UNIVERSITY OF MISSOURI
  • US20240229051A9 patent drawing
  • US20240229051A9 patent drawing
  • US20240229051A9 patent drawing

AI summary

The present disclosure is generally directed to gene editing in plant chloroplast and plant mitochondrial double-stranded DNA. Disclosed herein are cytosine base editors tailored for chloroplast and mitochondrial genomes in plants using plant-specific chloroplast and mitochondrial targeting peptides, a TALE, and a DNA deaminase. The systems of the present disclosure include DNA vectors and protocols to use them for gene editing in plants.